Glycogen Synthase Kinase 3β as a Likely Target for the Action of Lithium on Circadian Clocks
Abstract
Although lithium is one of the most commonly used drugs in the prophylaxis and treatment of bipolar disorder, the mechanisms underlying its therapeutic action are still unclear. Together with its mood-stabilizing effects, lithium is also known to influence the circadian clocks of several organisms including man. Circadian rhythms are altered in patients with bipolar disorder, and it is believed that these rhythms may play an important role in disease mechanisms. It is therefore possible that some of the therapeutic actions of lithium may be related to its effect on circadian clocks. Identifying the targets for lithium's action on circadian clocks would therefore be important both for understanding the mechanisms of its therapeutic effect and also in further understanding disease mechanisms in bipolar disorders. Using Drosophila melanogaster as a model system, we show that long-term administration of lithium results in lengthening of the free-running period (tau) of circadian locomotor activity rhythm of flies in constant darkness (DD). This effect occurs at concentrations similar to the plasma levels of lithium used in the treatment of bipolar disorder. The lithium-treated flies also show reduced activity of one of the previously reported targets of lithium action, Glycogen Synthase Kinase 3beta (GSK 3beta). GSK 3beta has been shown to be involved in the regulation of circadian clocks as the down regulation of this protein results in an elongation of tau. The tau elongation resembles the effect seen with lithium administration in a number of organisms including man, and taken together with the earlier observations our results suggest that lithium inhibits the activity of GSK 3beta to produce its effect on circadian clocks.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The effect of lithium and valproate on circadian rhythms likely involves the inhibition of GSK3β, which modifies multiple members of the molecular clock.
“This effect on circadian rhythms likely involves the inhibition of GSK3β which modifies multiple members of the molecular clock (Iwahana et al., 2004; Padiath et al., 2004; Gould and Manji, 2005; Iitaka et al., 2005; Yin et al., 2006).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Padiath et al., 2004
Cites
1 retracted
Ruel, L., Stambolic, V., Ali, A., Manoukian, A. S., & Woodgett, J. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21790 · Cited by 85 · see citing works
RetractedDavenport, Y. B., Adland, M. L., Gold, P. W., & Goodwin, F. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925 · see citing works
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567 · see citing works
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,305 · see citing works
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478 · see citing works
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · see citing works
Circadian rhythms from flies to human
Panda, S., Hogenesch, J. B., & Kay, S. A. (2002) · Nature · doi:10.1038/417329a · Cited by 1,044 · see citing works
Axonal Remodeling and Synaptic Differentiation in the Cerebellum Is Regulated by WNT-7a Signaling
Hall, A. C., Lucas, F. R., & Salinas, P. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80689-3 · Cited by 687 · see citing works
A common mechanism of action for three mood-stabilizing drugs
Williams, R. S. B., Cheng, L., Mudge, A. W., & Harwood, A. J. (2002) · Nature · doi:10.1038/417292a · Cited by 617 · see citing works
Crow, T. J. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.4.531-a · Cited by 562 · see citing works
Phase Advance of the Circadian Sleep-Wake Cycle as an Antidepressant
Wehr, T. A., Wirz-Justice, A., Goodwin, F. K., Duncan, W., & Gillin, J. C. (1979) · Science · doi:10.1126/science.227056 · Cited by 528 · see citing works
A Role for the Segment Polarity Gene shaggy/GSK-3 in the Drosophila Circadian Clock
Martinek, S., Inonog, S., Manoukian, A. S., & Young, M. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00383-x · Cited by 513 · see citing works
Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1
Lijam, N., Paylor, R., McDonald, M. P., Crawley, J. N., Deng, C.-X., Herrup, K., Stevens, K. E., Maccaferri, G., McBain, C. J., Sussman, D. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80354-2 · Cited by 470 · see citing works
The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 439 · see citing works
Moore, M. S., DeZazzo, J., Luk, A. Y., Tully, T., Singh, C. M., & Heberlein, U. (1998) · Cell · doi:10.1016/s0092-8674(00)81205-2 · Cited by 430 · see citing works
Peifer, M. A., Sweeton, D., Casey, M. J., & Wieschaus, E. F. (1994) · Development · doi:10.1242/dev.120.2.369 · Cited by 426 · see citing works
Glycogen synthase kinase-3: functions in oncogenesis and development
Plyte, S. E. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(92)90012-n · Cited by 377 · see citing works
Anti-bipolar therapy: mechanism of action of lithium
Jope, R. S. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000494 · Cited by 371 · see citing works
Roles of Wnt proteins in neural development and maintenance
Patapoutian, A., & Reichardt, L. F. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00100-8 · Cited by 319 · see citing works
Lucas, F. R., Goold, R., Gordon‐Weeks, P. R., & Salinas, P. C. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.10.1351 · Cited by 301 · see citing works
WNT-7a Induces Axonal Remodeling and Increases Synapsin I Levels in Cerebellar Neurons
Lucas, F. R., & Salinas, P. C. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8734 · Cited by 275 · see citing works
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264 · see citing works
Glycogen synthase kinase‐3β, mood stabilizers, and neuroprotection
Li, X., Bijur, G. N., & Jope, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.40201.x · Cited by 238 · see citing works
Helfrich‐Förster, C. (2000) · Journal of Biological Rhythms · doi:10.1177/074873040001500208 · Cited by 209 · see citing works
The Wnt Signaling Pathway in Bipolar Disorder
Gould, T. D., & Manji, H. K. (2002) · The Neuroscientist · doi:10.1177/107385802237176 · Cited by 173 · see citing works
Valproate Regulates GSK-3-Mediated Axonal Remodeling and Synapsin I Clustering in Developing Neurons
Hall, A. C., Brennan, A., Goold, R., Cleverley, K., Lucas, F. R., Gordon‐Weeks, P. R., & Salinas, P. C. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1117 · Cited by 167 · see citing works
Lithium therapy and signal transduction
Williams, R. S. B., & Harwood, A. J. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01428-5 · Cited by 158 · see citing works
Rhythms and the pharmacology of lithium
Klemfuss, H. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90037-z · Cited by 134 · see citing works
GSK-3 and the neurodevelopmental hypothesis of schizophrenia
Kozlovsky, N., Belmaker, R. H., & Agam, G. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00131-6 · Cited by 128 · see citing works
Benedetti, F., Barbini, B., Campori, E., Fulgosi, M. C., Pontiggia, A., & Colombo, C. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00034-6 · Cited by 110 · see citing works
Modeling human neurodegenerative diseases in Drosophila: on a wing and a prayer
Fortini, M., & Bonini, N. M. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01939-3 · Cited by 106 · see citing works
Fk, G., Wirz‐Justice, A., & Ta, W. (1982) · PubMed · Cited by 83 · see citing works
Drosophila melanogaster as a model system for drug discovery and pathway screening
Tickoo, S. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00206-0 · Cited by 78 · see citing works
Johnsson, A., Engelmann, W., Pflug, B., & Klemke, W. (1983) · PubMed · Cited by 64 · see citing works
Typical and Atypical Antidepressants. Clinical Practice
Tyrer, P. (1983) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.4.376-a · Cited by 54 · see citing works
Sheeba, V., Sharma, V. K., Chandrashekaran, M. K., & Joshi, A. (1999) · Die Naturwissenschaften · doi:10.1007/s001140050651 · Cited by 49 · see citing works
Self-citationLithium-related genetics of bipolar disorder
Detera-Wadleigb, S. D. (2001) · Annals of Medicine · doi:10.3109/07853890108998756 · Cited by 47 · see citing works
Bier, E., & Reiter, L. T. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.3.387 · Cited by 43 · see citing works
Sheeba, V., Chandrashekaran, M. K., Joshi, A., & Sharma, V. K. (2002) · Die Naturwissenschaften · doi:10.1007/s00114-002-0360-9 · Cited by 26 · see citing works
Self-citationA Simple Computer-aided Device for Monitoring Activity of Small Mammals and Insects
Sharma, V. K. (2003) · Biological Rhythm Research · doi:10.1076/brhm.34.1.3.14078 · Cited by 18 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Circadian genes, rhythms and the biology of mood disorders
McClung, C. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.003 · Cited by 666 · see citing works
Toward constructing an endophenotype strategy for bipolar disorders
Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423 · see citing works
Links between circadian rhythms and psychiatric disease
Karatsoreos, I. N. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00162 · Cited by 146 · see citing works
Assessment of circadian function in fibroblasts of patients with bipolar disorder
Yang, S., Van Dongen, H. P. A., Wang, K., Berrettini, W., & Bućan, M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.10 · Cited by 113 · see citing works
Ghaemi, S. N. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl061 · Cited by 107 · see citing works
Lithium- and Valproate-Induced Alterations in Circadian Locomotor Behavior in Drosophila
Dokucu, M. E., Yu, L., & Taghert, P. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300764 · Cited by 96 · see citing works
Role for the<i>Clock</i>Gene in Bipolar Disorder
McClung, C. A. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.031 · Cited by 57 · see citing works
- Authors
- Padiath, Q. S., Paranjpe, D., Jain, S., & Sharma, V. K.
- Affiliations
- National Centre for Biological Sciences (IN)
- Jawaharlal Nehru Centre for Advanced Scientific Research (IN)
- National Institute of Mental Health and Neurosciences (IN)
- Corresponding author
- Sharma, Vijay Kumar
- Venue
- Chronobiology International
- Publisher
- Informa UK Limited
- Published
- 2004-01
- Volume
- 21
- Issue
- 1
- Pages
- 43-55
- ISSN
- 0742-0528 (ISSN-L)
- 1525-6073
- OpenAlex
- W1997045509
- Cited by
- 64
- References
- 40
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 8 · 2015: 4 · 2014: 2 · 2013: 3 · 2012: 2
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chronobiology International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- California State Polytechnic University, Pomona
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
- Keywords
- lithium, glycogen synthase kinase-3β, circadian clock, free-running period, Drosophila melanogaster, bipolar disorder, mood stabilizers, circadian rhythm disruption
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Animals, Biological Clocks, Bipolar Disorder, Circadian Rhythm, Cytoskeletal Proteins, Drosophila melanogaster, Humans, Lithium, Male, Motor Activity, Transcription Factors, Trans-Activators, Drosophila Proteins, Glycogen Synthase Kinase 3, beta Catenin, Armadillo Domain Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review